1. /
  2. Our work /
  3. Projects /
  4. Eliminate Hepatitis C Australia (EC Australia)
Smiling health worker at Victorian Aboriginal Health Service.
Image: Kris Paulson
EC Australia Horizontal

Eliminate Hepatitis C Australia (EC Australia)

We're partnering to eliminate hepatitis C as a public health threat in Australia by 2030. 

The Eliminate Hepatitis C Australia (EC Australia) partnership brings together people with living and lived experience, community organisations, health services, government, researchers and implementation scientists. EC Australia is led by Burnet Institute, a global leader in hepatitis C research and implementation science. 

11

ongoing projects with our priority populations: Aboriginal and Torres Strait Islander Peoples, people who inject drugs, and people at risk of liver cancer.

70+

partners with research institutes, universities, health providers and community groups.

$6m

of EC Australia funds distributed to partners to deliver projects since 2019.

What we do

From 2023 to 2027, EC Australia is funded through Burnet. We’re working with Aboriginal and Torres Strait Islander Peoples, people who inject drugs and people at risk of liver cancer. These groups face greater hepatitis C health risks and unequal access to care.

Learn more about ongoing partner projects:

  • Women‐led peer health clinics for women who inject drugs (QuIHN

  • Testing and treatment for women who inject drugs accessing domestic violence services (Hepatitis SA

  • Peer-based referral program for Aboriginal people who inject drugs to get safe injecting equipment, testing and care (Peer Based Harm Reduction WA

  • 'Community of practice' for liver health and people who inject drugs (QuIHN

  • Regional health 'community of practice' with health workers and people who inject drugs (INHSU

  • Work and Development Order framework to let young people pay off fines by attending treatment and care. (Burnet, EC Australia) 

  • Culturally respectful video that Aboriginal-controlled health services can use to reduce stigma around needle and syringe programs (AHCWA)
  • Peer support programs in prisons that address hepatitis C and harm reduction among Aboriginal and Torres Strait Islander people. (QuIHN
  • Use qualitative research to explore the experiences of people who inject drugs who live with hepatitis C and liver cirrhosis (liver scarring). (Burnet, AIVL)
  • Use that research to develop a community‐based model of public health surveillance to track and monitor HCC, a type of liver cancer.
  • Analyse the cost‐effectiveness of our community-based model. 

What we've done

From 2019 to 2022, our project was funded by the Paul Ramsay Foundation. We: 

  • set up a network of more than 75 partner organisations and provided funding to key elimination activities  

  • delivered the first peer‐led national health promotion campaign (It’s Your Right

  • received $1.25 million to deliver the first national hepatitis C campaign for Aboriginal and Torres Strait Islander Peoples (Every Yarn Counts

  • funded and supported 21 implementation projects 

  • mapped policy priorities and coordinated a national advocacy committee  

  • secured an additional $21 million for partners and ongoing hepatitis C projects. 

Burnet Hep C Elimination 2025 image

Tracking our progress

Since 2019, we’ve worked with Kirby Institute to measure and publish a report on progress to eliminating hepatitis C as a public health threat.

Student opportunities

View 63 more

Elimination of hepatitis C through rapid testing and treatment in pharmacies

The project aims to explore the role of rapid testing in improving the hepatitis care cascade from infection and diagnosis to treatment and cure.

Students will be involved in implementation trials and evaluation of the effectiveness and acceptability of new rapid HCV diagnosis pathways. The outcomes will help facilitate treatment uptake and improve the quality of care.

Open to
  • Masters by research
  • Honours
  • PhD

Eliminating hepatitis C infection in Australia through harm reduction, education and treatment scale up

The project aims to explore:

  • improved harm reduction strategies 
  • workforce development and health service delivery 
  • supports needed for prescribers to start treatment. 

The outcomes will help facilitate treatment uptake and improve the quality of care.

Open to
  • Masters by research
  • Honours
  • PhD
View 63 more

Toolkits and guidance

Reports and recordings

Partners

Partners (A-M)

  • Aboriginal and Torres Strait Islander Community Health Service 
  • Aboriginal Health Council of Western Australia 
  • Aboriginal Health Services TAS 
  • Aboriginal Victoria 
  • ACT Health 
  • Alfred Health 
  • Alfred Hospital 
  • Australasian Society for HIV Medicine 
  • Australian Federation of AIDS Organisations 
  • Australian Hepatology Association 
  • Australian Injecting and Illicit Drug Users League 
  • Australian Medical Association 
  • Australian Primary Health Care Nurses Association 
  • Barwon Health 
  • Cairns Sexual Health Service 
  • Canberra Alliance of Harm Minimisation and Advocacy 
  • Centre for Social Research in Health 
  • Country SA Primary Health Network 
  • Danila Dilba Health Service 
  • Department of Health NSW 
  • Department of Health NT 
  • Department of Health QLD 
  • Department of Health TAS 
  • Department of Health WA 
  • Department of Health and Human Services VIC 
  • Doherty Institute 
  • East Melbourne Primary Health Care Collaborative 
  • Gastroenterological Society of Australia 
  • Harm Reduction Victoria 
  • Health Central Adelaide 
  • Hepatitis ACT 
  • Hepatitis Australia 
  • Hepatitis NSW 
  • Hepatitis QLD 
  • Hepatitis SA 
  • Hepatitis WA 
  • Hunter New England Local Health District 
  • Institute for Urban Indigenous Health 
  • Kirby Institute 
  • Kirketon Road Centre 
  • La Trobe University 
  • Liverpool Hospital 
  • LiverWELL
  • Menzies School of Health Research 
  • Monash University

Partners (N–Z)

  • Northern Territory AIDS and Hepatitis Council 
  • NSW Users and AIDS Association 
  • Peer-Based Harm Reduction WA 
  • Pharmaceutical Society of Australia 
  • Princess Margaret Hospital 
  • Queensland Injectors for Advocacy and Action 
  • Royal Adelaide Hospital 
  • Royal Australian College of General Practitioners 
  • Royal Melbourne Hospital 
  • Royal Perth Hospital 
  • Royal Prince Alfred Hospital 
  • SA Health 
  • Sexual Health and Blood Borne Viruses Evaluation Network (SIREN) 
  • Social Policy Research Centre 
  • South Australia Health and Medical Research Institute 
  • St Vincent's Hospital Melbourne 
  • TasCAHRD 
  • Tasmania Statewide Sexual Health Service 
  • Tasmanian Users Health and Support League 
  • Telethon Kids 
  • University of Melbourne 
  • University of NSW 
  • University of Queensland 
  • University of Sydney 
  • VHITTAL Committee of the North West Melbourne PHN 
  • Victorian Aboriginal Community Controlled Health Organisation 
  • WA Primary Health Alliance 
  • Western Australian Network of Alcohol and Other Drug Agencies 
  • Youth Link 
  • You Yangs Medical Clinic 

Funding partners

  • Paul Ramsay Foundation (2018-2022)
  • Commonwealth Department of Health (‘It’s Your Right’ and ‘Every Yarn Counts’ campaigns)(2021- 2022)
  • Commonwealth Department of Health and Aged Care (It’s Your Right)( 2025-2026)
  • Burnet Institute (2023-2027) 

Project contacts

Main contacts

Associate Professor Alisa Pedrana

Associate Professor Alisa Pedrana

Eliminate Hepatitis C Australia Coordinator
View profile
Group mailbox

EC Australia

Student supervisor contacts

Professor Joseph (Joe) Doyle

Professor Joseph (Joe) Doyle

Deputy Program Director, Disease Elimination; Co-Head, Infectious Diseases Clinical Research; President, Hepatitis Australia; NHMRC Clinical Research Fellow
View profile

Project team

Associate Professor Alisa Pedrana

Associate Professor Alisa Pedrana

Senior Research Fellow; Deputy Discipline Head, Public Health; Eliminate Hepatitis C Australia Coordinator
View profile
Paul Armstrong

Paul Armstrong

Co-lead Policy and Advocacy, Eliminate Hepatitis C Australia
View profile
Troy Combo

Troy Combo

Program Manager, Aboriginal Health Plan, EC Australia
View profile
Emily Adamson

Emily Adamson

Program Manager, Health Promotion, EC Australia
View profile
Freya Saich

Freya Saich

Lead Policy Officer, EC Australia
View profile
Dr Jacqui Richmond

Dr Jacqui Richmond

Program Manager, Workforce Development and Health Service Delivery, EC Australia
View profile
Dr Anna Wilkinson

Dr Anna Wilkinson

Senior Research Fellow
View profile
Associate Professor Nick Scott

Associate Professor Nick Scott

Head, Modelling and Biostatistics
View profile
Associate Professor Jessica Howell

Associate Professor Jessica Howell

Co-head, Hepatitis B and Liver Cancer; Senior Research Fellow
View profile
Shannon Christensen

Shannon Christensen

Research Assistant, Eliminate Hepatitis C Australia (EC Australia)
View profile
Dr Daisy Gibbs

Dr Daisy Gibbs

Evaluation Officer
View profile
Filip Djordjevic

Filip Djordjevic

Research Assistant
View profile
On this page